Parkinson’s disease is associated with abnormal beta wave activity in the subthalamic nucleus (STN), but a direct connection between this activity and movement difficulties has not yet been established. A study group at Osaka University developed a neurofeedback system which enables patients with Parkinson’s disease to voluntarily control beta wave activity in their deep brain associated with symptoms of the disorder. (February 6, 2019)
